BDR Pharma inks license agreement with DRDO to produce COVID-19 drug 2-DG

Last month, the Drugs Controller General of India (DCGI) had approved the oral medication for emergency usage as adjuvant therapy in mild to severe COVID-19 patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ycdgGU
via IFTTT